Acura Pharmaceuticals (OTCMKTS:ACUR) Stock Price Passes Below 200-Day Moving Average of $0.56

Acura Pharmaceuticals, Inc. (OTCMKTS:ACUR)’s stock price passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.56 and traded as low as $0.50. Acura Pharmaceuticals shares last traded at $0.54, with a volume of 7,633 shares traded.

The company has a market cap of $35.15 million, a PE ratio of -18.00 and a beta of 0.59. The company has a current ratio of 0.86, a quick ratio of 0.86 and a debt-to-equity ratio of 1.97. The firm’s 50-day simple moving average is $0.53 and its two-hundred day simple moving average is $0.56.

About Acura Pharmaceuticals (OTCMKTS:ACUR)

Acura Pharmaceuticals, Inc is a pharmaceutical company, which engages in the research, development, and commercialization of abuse deterrent, orally administered pharmaceutical products. Its technology platforms include AVERSION, IMPEDE, and LIMITX. The company was founded on April 10, 1935 and is headquartered in Palatine, IL.

Recommended Story: Book Value Of Equity Per Share – BVPS Explained

Receive News & Ratings for Acura Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acura Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.